Armen Yuri Gasparyan
Gasparyan A, Ayvazyan L, Pretorius E, Kitas G. Platelets in rheumatic diseases: friend or foe?. Curr Pharm Des. 2014;20:552-66 pubmed
..Taken together, current evidence necessitates a balanced approach to platelet-activating and suppressing drug therapies in inflammatory rheumatic diseases. ..
Gasparyan A, Ayvazyan L, Yessirkepov M, Kitas G. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 2015;11:1781-94 pubmed publisher
..Certain drugs (macrolides, statins), comorbidities and certain genetic factors increase risk of colchicine toxicity. ..
Gasparyan A, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas G. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39:345-357 pubmed publisher
..Interpretation of PLR combined with complementary hematologic indices is advisable to more accurately diagnose inflammatory rheumatic diseases and predict related comorbidities. ..
Gasparyan A, Ayvazyan L, Akazhanov N, Kitas G. Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J. 2013;54:600-8 pubmed
..It also considers joint efforts of authors, peer reviewers and editors as a foundation for appropriately defining and disclosing potential COIs. ..
Gasparyan A, Sandoo A, Stavropoulos Kalinoglou A, Kitas G. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-? therapy. Rheumatol Int. 2010;30:1125-9 pubmed publisher
..More prospective studies with large numbers of patients are warranted to ascertain associations of high and low values of MPV with diverse markers of inflammation and vascular pathology. ..
Gasparyan A, Yessirkepov M, Gorin S, Kitas G. Educating science editors: is there a comprehensive strategy?. Croat Med J. 2014;55:672-5 pubmed
..Networking with like-minded specialists within the global and regional editorial associations seems a useful strategy to upgrade editorial skills and resolve problems with the quality control and digitization of scholarly periodicals. ..
Gasparyan A. Aspirin and clopidogrel resistance: methodological challenges and opportunities. Vasc Health Risk Manag. 2010;6:109-12 pubmed
..This commentary highlights some limitations of studies on aspirin and clopidogrel resistance in patients undergoing coronary interventions. ..
Gasparyan A, Ayvazyan L, Cocco G, Kitas G. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des. 2012;18:1543-55 pubmed
..Future prospective studies should specifically investigate the cardiovascular safety of most antirheumatic drugs as part of mono- or combination therapy in relation to different dosage regimens, duration of therapy, age, and gender. ..
Gasparyan A, Yessirkepov M, Voronov A, Gorin S, Koroleva A, Kitas G. Statement on Publication Ethics for Editors and Publishers. J Korean Med Sci. 2016;31:1351-4 pubmed publisher